Salarius Pharmaceuticals, Inc. (SLRX) NASDAQ
0.84
+0.19(+29.23%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 312,453.65 |
| Enterprise Value | -10.4M |
| P/E Ratio | -0.35 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 1.18 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.25 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
Management Effectiveness
| Return On Assets | -1.55 |
| Return On Equity | -3.95 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -8.52M |
| EBITDA | -12.61M |
| Net Income | -12.52M |
| Diluted EPS | -25.99 |
Balance Sheet
| Total Cash | 7.82M |
| Total Cash/Share | 14.7 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 1.84 |
| Book Value Per Share | 7.29 |
Price History
| 52-Week Change | -97.21 |
| 52-Week High | 52.95 |
| 52-Week Low | 0.52 |
| Moving Average 50 Days | 1.12 |
| Moving Average 200 Days | 6.94 |
Statistics
| Average Volume | 3.68M |
| Shares Outstanding | 5.86M |
| % Held by Institutions | 16.46 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:15 |
| Last Split Date | August 18, 2025 |
